Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$361M |
| 2 |
CVS Health
CVS
|
+$180M |
| 3 |
Cigna
CI
|
+$158M |
| 4 |
Microsoft
MSFT
|
+$102M |
| 5 |
Amazon
AMZN
|
+$90M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$301M |
| 2 |
AET
Aetna Inc
AET
|
+$270M |
| 3 |
PX
Praxair Inc
PX
|
+$184M |
| 4 |
ANDV
Andeavor
ANDV
|
+$97.3M |
| 5 |
COL
Rockwell Collins
COL
|
+$89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.86% |
| 2 | Financials | 13.99% |
| 3 | Healthcare | 13.63% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Veracyte
VCYT
$3.7B
| $1.44M | ﹤0.01% |
114,349
+5,472
| +5% | +$64.7K |
|
|
HPR
2427
DELISTED
HighPoint Resources Corporation
HPR
| $1.44M | ﹤0.01% |
11,552
-230
| -2% | -$42.4K |
|
2428
Byline Bancorp
BY
$1.78B
| $1.44M | ﹤0.01% |
86,172
-1,196
| -1% | -$24.1K |
|
|
GNMK
2429
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1.44M | ﹤0.01% |
295,386
-3,756
| -1% | -$19.6K |
|
2430
TG Therapeutics
TGTX
$7.96B
| $1.43M | ﹤0.01% |
348,214
+18,567
| +6% | +$92.3K |
|
|
GSKY
2431
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $1.42M | ﹤0.01% |
148,287
-2,712
| -2% | -$31.6K |
|
|
ELOX
2432
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $1.42M | ﹤0.01% |
2,951
+183
| +7% | +$101K |
|
|
SPNE
2433
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $1.41M | ﹤0.01% |
77,367
+13,106
| +20% | +$221K |
|
2434
VSE Corp
VSEC
$5.45B
| $1.41M | ﹤0.01% |
47,150
+3,724
| +9% | +$112K |
|
|
CBLK
2435
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $1.41M | ﹤0.01% |
104,890
+62,600
| +148% | +$1.03M |
|
2436
Atlanta Braves Holdings Series A
BATRA
$3.49B
| $1.4M | ﹤0.01% |
56,241
+5,900
| +12% | +$149K |
|
2437
Alaunos Therapeutics
TCRT
$4.59M
| $1.39M | ﹤0.01% |
4,960
+438
| +10% | +$173K |
|
|
SFIX
2438
Stitch Fix
SFIX
$536M
| $1.39M | ﹤0.01% |
81,079
+28,357
| +54% | +$702K |
|
2439
Franklin Covey
FC
$242M
| $1.39M | ﹤0.01% |
61,983
+1,156
| +2% | +$25.8K |
|
|
PLYA
2440
DELISTED
Playa Hotels & Resorts
PLYA
| $1.38M | ﹤0.01% |
192,302
-3,680
| -2% | -$29.8K |
|
2441
WIX.com
WIX
$2.3B
| $1.38M | ﹤0.01% |
+15,258
| New | +$1.44M |
|
2442
Tenable Holdings
TENB
$3.6B
| $1.38M | ﹤0.01% |
61,974
-740
| -1% | -$21K |
|
2443
KRONOS Worldwide
KRO
$693M
| $1.37M | ﹤0.01% |
118,534
+6,900
| +6% | +$93K |
|
2444
Ribbon Communications
RBBN
$377M
| $1.35M | ﹤0.01% |
280,465
+3,833
| +1% | +$22.2K |
|
|
PIR
2445
DELISTED
Pier 1 Imports, Inc.
PIR
| $1.35M | ﹤0.01% |
220,020
+42,625
| +24% | +$1.17M |
|
|
DERM
2446
DELISTED
Dermira, Inc.
DERM
| $1.34M | ﹤0.01% |
186,501
-2,524
| -1% | -$27.6K |
|
|
USAK
2447
DELISTED
USA Truck Inc
USAK
| $1.34M | ﹤0.01% |
89,463
| – | – |
|
2448
Cushman & Wakefield Ltd
CWK
$3.14B
| $1.34M | ﹤0.01% |
92,422
+6,332
| +7% | +$106K |
|
2449
Yeti Holdings
YETI
$3.71B
| $1.33M | ﹤0.01% |
+89,503
| New | +$1.42M |
|
|
HK
2450
DELISTED
Halcon Resources Corporation
HK
| $1.33M | ﹤0.01% |
780,408
-2,198
| -0.3% | -$6.87K |
|
Similar funds
Charles Schwab's Q4 2018 Portfolio in Review
As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
- Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
- Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
- Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
- Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
- Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
- Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.